TY - JOUR
T1 - Wolfram syndrome 1 gene regulates pathways maintaining beta-cell health and survival
AU - Abreu, Damien
AU - Asada, Rie
AU - Revilla, John M.P.
AU - Lavagnino, Zeno
AU - Kries, Kelly
AU - Piston, David W.
AU - Urano, Fumihiko
N1 - Publisher Copyright:
© 2020, The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Wolfram Syndrome 1 (WFS1) protein is an endoplasmic reticulum (ER) factor whose deficiency results in juvenile-onset diabetes secondary to cellular dysfunction and apoptosis. The mechanisms guiding β-cell outcomes secondary to WFS1 function, however, remain unclear. Here, we show that WFS1 preserves normal β-cell physiology by promoting insulin biosynthesis and negatively regulating ER stress. Depletion of Wfs1 in vivo and in vitro causes functional defects in glucose-stimulated insulin secretion and insulin content, triggering Chop-mediated apoptotic pathways. Genetic proof of concept studies coupled with RNA-seq reveal that increasing WFS1 confers a functional and a survival advantage to β-cells under ER stress by increasing insulin gene expression and downregulating the Chop-Trib3 axis, thereby activating Akt pathways. Remarkably, WFS1 and INS levels are reduced in type-2 diabetic (T2DM) islets, suggesting that WFS1 may contribute to T2DM β-cell pathology. Taken together, this work reveals essential pathways regulated by WFS1 to control β-cell survival and function primarily through preservation of ER homeostasis.
AB - Wolfram Syndrome 1 (WFS1) protein is an endoplasmic reticulum (ER) factor whose deficiency results in juvenile-onset diabetes secondary to cellular dysfunction and apoptosis. The mechanisms guiding β-cell outcomes secondary to WFS1 function, however, remain unclear. Here, we show that WFS1 preserves normal β-cell physiology by promoting insulin biosynthesis and negatively regulating ER stress. Depletion of Wfs1 in vivo and in vitro causes functional defects in glucose-stimulated insulin secretion and insulin content, triggering Chop-mediated apoptotic pathways. Genetic proof of concept studies coupled with RNA-seq reveal that increasing WFS1 confers a functional and a survival advantage to β-cells under ER stress by increasing insulin gene expression and downregulating the Chop-Trib3 axis, thereby activating Akt pathways. Remarkably, WFS1 and INS levels are reduced in type-2 diabetic (T2DM) islets, suggesting that WFS1 may contribute to T2DM β-cell pathology. Taken together, this work reveals essential pathways regulated by WFS1 to control β-cell survival and function primarily through preservation of ER homeostasis.
UR - http://www.scopus.com/inward/record.url?scp=85079466121&partnerID=8YFLogxK
U2 - 10.1038/s41374-020-0408-5
DO - 10.1038/s41374-020-0408-5
M3 - Article
C2 - 32060407
AN - SCOPUS:85079466121
SN - 0023-6837
VL - 100
SP - 849
EP - 862
JO - Laboratory Investigation
JF - Laboratory Investigation
IS - 6
ER -